Vici Health Sciences, a leading pharmaceutical development and regulatory services provider, has announced the launch of its Phase I, Phase II, and Phase III clinical supplies manufacturing services. This expansion aims to provide biotech and pharmaceutical companies with high-quality manufacturing solutions, streamlining the path from early-stage research to commercialization.
Integrated Clinical Supplies Manufacturing
Addressing the increasing demand for efficient and reliable clinical supplies, Vici Health Sciences is expanding its capabilities to include the manufacturing of clinical trial materials such as capsules, tablets, and oral liquids. These services are designed to meet the specific requirements of each clinical development phase, ensuring compliance, quality, and timely delivery to support critical research timelines.
Comprehensive Service Offerings
"Adding clinical supplies manufacturing to our portfolio allows us to offer a complete suite of services to our clients," said Anish Dhanarajan, PhD, CEO at Vici Health Sciences. "We understand the complexities of clinical research and development, and our goal is to simplify the process for our partners by providing a seamless transition from formulation development to clinical supplies manufacturing."
The new clinical supply manufacturing services include:
- Phase I Manufacturing: Small-scale production for early-phase trials, focusing on flexibility and rapid turnaround.
- Phase II and Phase III Manufacturing: Expanded capacity for mid- to late-stage trials, emphasizing scalability, process optimization, and regulatory compliance.
- GMP Compliance: All clinical manufacturing operations adhere to strict Good Manufacturing Practice (GMP) standards, ensuring the highest level of product quality and safety.
- Packaging and Labeling: Customized packaging and labeling solutions to meet specific clinical trial requirements, including blinding and randomization.
Streamlining Drug Development
By integrating clinical supplies manufacturing with its existing formulation, analytical, and regulatory services, Vici Health Sciences offers a comprehensive solution for drug development. This expansion enables the company to act as a single-source partner, helping clients navigate the complexities of drug development while minimizing risk and maximizing efficiency.
